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INTRODUCTION
Malignant transformation of a neurilemmoma is an exceed-
ingly rare event. Review of the available literature revealed
only a few other similar cases documenting malignant trans-
formation of a solitary benign neurilemmoma in a patient
without von Recklinghausen’s disease (1-11). We report a
case of intrathoracic ancient neurilemmoma undergoing a
malignant change in a 39-yr-old man.
CASE REPORT
A 39-yr-old man presented with right flank and chest pain
for several months. Plain radiography and CT scan of the
chest showed a heterogeneous enhancing soft tissue mass at
the extrapleural space with erosion of the surrounding ribs
at the right basal lung area (Fig. 1). Laboratory findings were
normal. The patient had no history of specific disease or irra-
diation. There were no stigmata of von Recklinghausen’s
disease. Operative findings showed extrapleural mass on the
posterior aspect of the 8th and 9th ribs of the right thoracic
cavity. The tumor was considered to arise from intercostal
nerve but attached nerve was not found. Excisional biopsy was
performed. The excised mass was encapsulated and measured
4.5×3.5×2.3 cm. The cut surface was grayish-white and
glistening with a focal cystic change and hemorrhage. Necro-
sis was not seen (Fig. 2).
Histologically, the tumor revealed predominant Antoni A
areas and focal B areas (Fig. 3). These two components blend
imperceptively. The Antoni A areas were composed of com-
pact spindle cells that had twisted nuclei and indistinct cyto-
plasmic borders. They were arranged in short bundles. Nu-
clear palisading, whorling of the cells, and Verocay bodies
were present. The hypocellular Antoni B areas showed a
loosely textured matrix, microcystic change, delicate colla-
gen fibers, and large irregularly spaced vessels with promi-
nent perivascular hyalinization. A degenerative change with
stromal hemosiderin deposition and enlarged pleomorphic
nuclei were noted. In the cellular Antoni A areas, there
were diffuse, ill defined, obviously malignant foci showing
a markedly increased cellularity, long fascicular arrangement
of hyperchromatic spindle cells, frequent mitotic figures, and
loss of the original neurilemmomatous feature. The spindle
cells were uniform in size and shape but became more plump.
There were 5 mitotic figures per 1 high-power field at the
most active hypercellular area (Fig. 4). Immunohistochemi-
cal finding for S-100 protein demonstrated diffuse strong
positivity in benign neurilemmomatous areas (Fig. 5A) and
very weak positivity in malignant foci (Fig. 6A). Immuno-
histochemical finding for MIB1 revealed a very low MIB1
index (less than 1%) in benign neurilemmomatous areas
(Fig. 5B) and a very high MIB1 index (greater than 60%)
in malignant foci (Fig. 6B). The malignant component
comprised about two thirds of the tumor but remained
encapsulated.
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Malignant Transformation of Intrathoracic Ancient Neurilemmoma 
in a Patient without Von Recklinghausen's Disease
Malignant transformation of a neurilemmoma is an exceedingly rare event. We
describe a case of intrathoracic ancient neurilemmoma undergoing a malignant
change in a 39-yr-old man. The patient presented with right flank and chest pain
for several months. Plain radiography and CT scan of the chest showed a soft
tissue mass lesion at the extrapleural space with erosion of surrounding ribs at
the right basal lung area. The excised mass was encapsulated and measured
4.5×3.5×2.3 cm. The cut surface showed grayish-white and glistening with a
focal cystic change and hemorrhage. Necrosis was not seen. Histologically, the
tumor showed the features of classic neurilemmoma composed of the Antoni
type A and B areas with perivascular hyalinization. In addition, obviously histo-
logically malignant foci manifested by presence of markedly increased cellularity
with fascicular arrangement, active mitotic activity, hyperchromasia, and gradual
loss of original neurilemmomatous feature were noted. 
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DISCUSSION
Neurilemmomas are encapsulated benign neoplasms of
nerve sheath origin with a well defined histologic feature (12).
Neurilemmomas comprise the most frequent lesion among
various neurogenic tumors encountered within the thorax
or mediastinum (13). Almost all of the neurilemmomas of
this anatomic location originate from the posterior medias-
tinum or paravertebral chest wall, and present as a slow grow-
ing, well-defined mass projecting into the thoracic cavity. Pain
and neurologic symptoms are uncommon unless the tumor
becomes large. Patients with a malignant change in neurilem-
momas typically presented with pain or rapid enlargement
of a pre-existing lesion (9). In our case the patient presented
Fig. 1. CT scan of the chest shows a soft tissue mass lesion at
the extrapleural space with erosion of the surrounding ribs at the
right basal lung area.
Fig. 2. The excised mass was encapsulated and measured 4.5
×3.5×2.3 cm. The cut surface shows grayish-white and is glis-
tening with a focal cystic change and hemorrhage. Necrosis is
not seen.
Fig. 3. The tumor shows the features of classic neurilemmoma
composed of the Antoni type A and B areas with perivascular
hyalinization (H&E, ×40).
Fig. 4. The tumor cells shows spindle shaped nuclei, hyperchro-
masia, high mitotic activity, and loss of the original neurilemmo-
matous feature (H&E, ×400).Malignant Transformation of Neurilemmoma  297
with right flank and chest pain for several months.
The characteristic pathologic features include encapsula-
tion and distinct histologic features composed of Antoni type
A and B tissues. Malignant peripheral nerve sheath tumors
(MPNSTs) have a varied origin. A majority originate in pa-
tients with neurofibromatosis (NF)-1, presumably from an
antecedent neurofibroma, often plexiform in type (14, 15).
The remaining cases are tumors arising from neurofibromas
in patients without stigmata of NF-1, de novo from a peri-
pheral nerve (14, 15), from a peripheral nerve exposed to
radiation (16, 17), from Schwann cells in a ganglioneuroma
or ganglioneuroblastoma (18) and, most infrequently, from
an antecedent benign neurilemmoma. 
The present case had the following features of Woodruff et
al. (8) criteria for the diagnosis of MPNST arising in a neuri-
lemmoma: (a) presence of benign neurilemmoma; (b) failure
to identify a primary tumor that might have metastasized to
the neurilemmoma; and (c) presence within the substance of
the neurilemmoma of a histologically malignant cell popu-
lation. Regardless of their origin, the vast majority of MPNSTs
are characterized histologically by densely packed, interlacing
fascicles of hyperchromatic, mitotically active spindle cells.
The exception to this is the MPNST arising from a neurilem-
moma. In most cases of neurilemmoma with malignant trans-
formation, the malignant component revealed predominantly
or purely epithelioid differentiation (8, 9). In the minor cases,
the malignant component showed small cells with neuroepi-
thelial differentiation (8) and angiosarcoma (9, 19). Woodruff
et al. (8) reviewed nine cases of MPNSTs arising in benign
neurilemmomas and described clinical and pathologic dif-
ferences between MPNSTs arising in neurilemmomas and
conventional MPNSTs. MPNSTs arising in benign neurilem-
momas show slight male predilection, occurrence in an older
age group (a mean age of 56 yr, 20 yr older than the mean
age for patients with conventional MPNSTs), a long history
of an antecedent mass, and no association with NF type 1 or 2.
Histologically, the malignant component was composed of
commonly pure epithelioid (seven of nine cases) and small
cells with neuroepithelial features (two of nine cases). McMe-
namin et al. (9) reported the spectrum of the malignant change
in neurilemmoma. They reviewed 17 cases of neurilemmo-
mas which undergoing a malignant change. They identified
four cases of pure epithelioid MPNST, ten cases with a epithe-
lioid malignant change, and four cases of angiosarcoma. The
incidence and degree of epithelioid differentiation varied
according to the origin of MPNST. A predominantly epithe-
lioid differentiation occurs more frequently in MPNST from
patients without NF-1 (8, 9, 20), while the epithelioid dif-
ferentiation is uncommon in other forms of MPNST (20, 21).
Thus, the neurilemmoma with malignant transformation is
unique among MPNST for its high incidence of usually non-
mucinous purely epithelioid differentiation (8). In contrast
to the Woodruff et al. and McMenamin et al. reports, the
present case was a 39-yr-old patient and the malignant com-
ponent revealed conventional spindle cell cytomorphology.
Epithelioid malignant change, epithelioid MPNST, or small
cell neuroepithelial-like cytomorphology was not identified
in our case. None of the cases of Woodruff et al. (8) and McMe-
namin et al. (9) showed the malignant component in an inter-
lacing, fasciculated spindle cell tumor. Review of the available
literature revealed only a few cases similar to our case (1-11).
Neurilemmoma with a malignant change showed several
Fig. 5. Immunohistochemical stain for S-100 protein (A) and MIB1
(B) in benign areas reveal intense nuclear and cytoplasmic immu-
noreactivity for S-100 protein and a very low MIB1 index (×200).
A B
Fig. 6. Immunohistochemical stain for S-100 protein (A) and MIB1
(B) in malignant areas reveal very weak immunoreactivity for S-
100 protein and a very high MIB1 index (×200).
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distinctions from the conventional MPNST including an
absence of geographic necrosis (15), heterologous elements
such as glands (22), osteo/chondrosarcoma and rhabdomyosar-
coma (23, 24), and the rarity of intercellular mucin in the
epithelioid cell areas (8). No coincident heterologous elements
were present in our case. The differential diagnosis of this
lesion includes spindle cell sarcoma and cellular schwanno-
ma. Presence of residual benign neurilemmoma tissues and
immunohistochemistry can help to distinguish MPNST from
spindle cell sarcoma and cellular schwannoma. The cellular
schwannoma has similar clinical characteristics but has a
higher recurrence rate (25). It consists mostly of hypercellu-
lar Antoni A tissue, is devoid of Verocay bodies, and 28% of
the cases have been mistaken for a malignant tumor (25, 26).
But a cellular schwannoma shows complete encapsulation,
focal presence of subcapsular loose areas reminiscent of the
Antoni B tissue, hyalinized thick-walled blood vessels, peri-
vascular lymphoid infiltrates, collection of lipid-laden histi-
ocytes, and diffuse strong expression of S-100 protein (8).
The prognosis for patients with neurilemmomas under-
going a malignant change is poor. The prognosis for epithe-
lioid MPNST arising in a neurilemmoma has been poor, with
less than 20% of patients surviving 5 yr (8). In our case the
patient was well with no evidence of disease for 11 months.
In summary, we described a case of ancient neurilemmoma
undergoing malignant trabsformation. The malignant foci
demonstrated markedly increased cellularity with fascicular
arrangement of hyperchromatic spindle cells with high mitot-
ic activity and loss of the original neurilemmomatous feature.
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